Latest Form 4 insider transactions

NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on September 25, 2026.
NYSE
Heidi O'Neill, a Director of Lithia Motors Inc, reported a transaction in 540 shares of common stock on September 25, 2026.
NYSE
Theodore H Bunting Jr, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.
NASDAQ
Sudarshan Hebbar, Chief Medical Officer of CalciMedica, Inc., received 180,000 shares of common stock on September 24, 2026.
NASDAQ
Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc., received 4,390 shares of common stock on September 25, 2026.
NYSE
Kevin Bradicich, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.
NASDAQ
Kenneth A. Stauderman, Chief Scientific Officer of CalciMedica, Inc., received 180,000 shares of common stock on September 24, 2026.
NYSE
Francisco Aristeguieta, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.
NYSE
Elizabeth A Ward, a Director of Hanover Insurance Group, Inc., received 4 shares of common stock on September 25, 2026.
NASDAQ
Stephen Bardin, Chief Financial Officer of CalciMedica, Inc., received 190,000 shares of common stock on September 24, 2026.
NYSE
Esta E Stecher, a Director of Jackson Financial Inc., received 355 shares of common stock on September 24, 2026.
NYSE
Drew Lawton, a Director of Jackson Financial Inc., received 208 shares of common stock on September 24, 2026.
NYSE
Derek G Kirkland, a Director of Jackson Financial Inc., received 103 shares of common stock on September 24, 2026.
NYSE
Steven A Kandarian, a Director of Jackson Financial Inc., received 784 shares of common stock on September 24, 2026.
NYSE
Bryan J Salvatore, Executive Vice President of Hanover Insurance Group, Inc., received 24 shares of common stock on September 25, 2026.
NASDAQ
Hartree Partners, LP reported changes in beneficial ownership of Hudson Technologies Inc /Ny common stock on September 24, 2026.
NYSE
Lily Fu Claffee, a Director of Jackson Financial Inc., received 329 shares of common stock on September 24, 2026.
NASDAQ
A. Rachel Leheny, CHIEF EXECUTIVE OFFICER and a Director of CalciMedica, Inc., received 360,000 shares of common stock on September 24, 2026.
NYSE
John C Roche, President and CEO and a Director of Hanover Insurance Group, Inc., received 120 shares of common stock on September 25, 2026.
NYSE
Preston Wendell Wells, VP, Chief Financial Officer of Stryker Corp, reported a transaction in 109 shares of common stock on September 24, 2026.
NYSE
Mark E. Foster, EVP, GC & Secretary of American Healthcare REIT, Inc., sold 1,500 shares of common stock on September 25, 2026 for $52.06 per share.
NYSE
Patricia A. Norton-Gatto, SVP & Princpl. Accntg. Officer of Hanover Insurance Group, Inc., received 6 shares of common stock on September 25, 2026.
NYSE
David John Lovely, Executive Vice President of Hanover Insurance Group, Inc., received 10 shares of common stock on September 25, 2026.
NYSE
Maureen Lally-Green, a Director of CNX Resources Corp, reported multiple transactions in common stock on September 24, 2026.
NYSE
Christopher Raub, EVP JFI; CEO PPM America of Jackson Financial Inc., reported multiple transactions in common stock on September 24, 2026.
NYSE
Jevin Eagle, a Director of Carters Inc, received 15 shares of common stock on September 25, 2026.
NYSE
Laura Louene Prieskorn, CEO and President and a Director of Jackson Financial Inc., reported multiple transactions in common stock on September 24, 2026.
NYSE
Don W Cummings, EVP and CFO of Jackson Financial Inc., reported multiple transactions in common stock on September 24, 2026.
NYSE
Carrie Chelko, EVP and General Counsel of Jackson Financial Inc., reported multiple transactions in common stock on September 24, 2026.
NYSE
Savvas Steve Panagiotis Binioris, EVP and Chief Risk Officer of Jackson Financial Inc., reported multiple transactions in common stock on September 24, 2026.